Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease. [electronic resource]
- Journal of the neurological sciences Jan 2007
- 130-4 p. digital
Publication Type: Journal Article
0022-510X
10.1016/j.jns.2006.10.018 doi
Adult Aged Aged, 80 and over Antiparkinson Agents--adverse effects Dyskinesia, Drug-Induced--epidemiology Female Genetic Predisposition to Disease--epidemiology Homozygote Humans Levodopa--adverse effects Male Middle Aged Parkinson Disease--drug therapy Peptidyl-Dipeptidase A--genetics Polymorphism, Genetic Predictive Value of Tests Psychoses, Substance-Induced--epidemiology Risk Factors